Seoul St. Mary's Hospital selected the first research-oriented hospital...Prove global research capabilities and infrastructure
Mar 28, 2025
The Catholic University of Korea's Seoul St. Mary's Hospital has been selected as the first certified research-oriented hospital by the Ministry of Health and Welfare, and by 2028, the transition to a global research-oriented hospital based on the convergence of medical care and research will begin in earnest.
Seoul St. Mary's Hospital has been striving to establish sustainable research-oriented governance aimed at social values, with the vision of a `global research-oriented hospital that realizes global advanced medical care.' To realize this, the hospital has been pushing for the four goals of ▲ establishing governance for health care research and commercialization ▲ establishing a sustainable R&D commercialization system ▲ upgrading the commercialization system based on an open platform ▲ realizing social values through global leading research.
As a major competitive edge, hospitals are expected to make the most of the characteristics of the Medical Life Industry Research Institute, POSTECH-Catholic University's Bioengineering Institute, and medical schools gathering together in the same complex. Unlike other research-oriented hospitals, which are spatially separated from existing research complexes, the key strategy is to quickly and efficiently carry out the entire process of clinical application through convergence research from basic research to convergence research.
To this end, the hospital has established the Research-Centered Hospital Certification Evaluation Project Promotion Team under the direct control of the Vice-President and Medical Center to systematize research governance that integrates the capabilities of Catholic Central Medical Center and medical schools, and has strengthened the function of the research-research support-administrative system.
In particular, large pharmaceutical companies and promising bio startups move in, and 'Omnibus Park', a one-stop cluster where industry-academic cooperation can collaborate in real-time, opened in May 2022 and has become a focal point, and the strength of the hospital seems to be further maximized.
Based on the three major research platforms known as the specialized fields of Seoul St. Mary's Hospital, 'blood/immune diseases', 'digital clinical' and 'precision regenerative medicine', we will focus on seven detailed fields (▲blood diseases, ▲ intractable autoimmunity, ▲ dielectric, ▲ big data artificial intelligence, ▲ smart medical devices, ▲ artificial organoid, ▲ cell therapy). In 2021, it was designated as the first advanced regenerative medical practice institution in university hospitals, and it has focused on developing next-generation treatments such as stem cell therapy and immune cell therapy by operating a cell therapy business group.
In addition, hospitals are expected to provide research facilities to outside researchers through open laboratories, revitalize cooperative research, and expand open innovation that contributes to the development of the health care industry across the country.
"The research infrastructure and global research capabilities that have been accumulated so far have become more recognized through the certification of research-oriented hospitals," said Yoon Seung-gyu, head of Seoul St. Mary's Hospital. "We will make efforts to present new directions for health care innovation through creative convergence technology research and to contribute to the development of customized medical care and the promotion of public health."
Seoul St. Mary's Hospital has been striving to establish sustainable research-oriented governance aimed at social values, with the vision of a `global research-oriented hospital that realizes global advanced medical care.' To realize this, the hospital has been pushing for the four goals of ▲ establishing governance for health care research and commercialization ▲ establishing a sustainable R&D commercialization system ▲ upgrading the commercialization system based on an open platform ▲ realizing social values through global leading research.
As a major competitive edge, hospitals are expected to make the most of the characteristics of the Medical Life Industry Research Institute, POSTECH-Catholic University's Bioengineering Institute, and medical schools gathering together in the same complex. Unlike other research-oriented hospitals, which are spatially separated from existing research complexes, the key strategy is to quickly and efficiently carry out the entire process of clinical application through convergence research from basic research to convergence research.
To this end, the hospital has established the Research-Centered Hospital Certification Evaluation Project Promotion Team under the direct control of the Vice-President and Medical Center to systematize research governance that integrates the capabilities of Catholic Central Medical Center and medical schools, and has strengthened the function of the research-research support-administrative system.
In particular, large pharmaceutical companies and promising bio startups move in, and 'Omnibus Park', a one-stop cluster where industry-academic cooperation can collaborate in real-time, opened in May 2022 and has become a focal point, and the strength of the hospital seems to be further maximized.
Based on the three major research platforms known as the specialized fields of Seoul St. Mary's Hospital, 'blood/immune diseases', 'digital clinical' and 'precision regenerative medicine', we will focus on seven detailed fields (▲blood diseases, ▲ intractable autoimmunity, ▲ dielectric, ▲ big data artificial intelligence, ▲ smart medical devices, ▲ artificial organoid, ▲ cell therapy). In 2021, it was designated as the first advanced regenerative medical practice institution in university hospitals, and it has focused on developing next-generation treatments such as stem cell therapy and immune cell therapy by operating a cell therapy business group.
In addition, hospitals are expected to provide research facilities to outside researchers through open laboratories, revitalize cooperative research, and expand open innovation that contributes to the development of the health care industry across the country.
"The research infrastructure and global research capabilities that have been accumulated so far have become more recognized through the certification of research-oriented hospitals," said Yoon Seung-gyu, head of Seoul St. Mary's Hospital. "We will make efforts to present new directions for health care innovation through creative convergence technology research and to contribute to the development of customized medical care and the promotion of public health."
|
This article was translated by Naver AI translator.
